These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 17916258

  • 1. The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials.
    Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L.
    Health Qual Life Outcomes; 2007 Oct 04; 5():56. PubMed ID: 17916258
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Assessing the ability of topiramate to improve the daily activities of patients with migraine.
    Brandes JL, Kudrow DB, Rothrock JF, Rupnow MF, Fairclough DL, Greenberg SJ.
    Mayo Clin Proc; 2006 Oct 04; 81(10):1311-9. PubMed ID: 17036556
    [Abstract] [Full Text] [Related]

  • 4. Topiramate improves health-related quality of life when used to prevent migraine.
    Diamond M, Dahlöf C, Papadopoulos G, Neto W, Wu SC.
    Headache; 2005 Sep 04; 45(8):1023-30. PubMed ID: 16109116
    [Abstract] [Full Text] [Related]

  • 5. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul 04; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.
    Headache; 2009 Sep 04; 49(8):1153-62. PubMed ID: 19719543
    [Abstract] [Full Text] [Related]

  • 9. Analysis of pooled data from two pivotal controlled trials on the efficacy of topiramate in the prevention of migraine.
    Freitag FG, Forde G, Neto W, Wang DZ, Schmitt J, Wu SC, Hulihan J.
    J Am Osteopath Assoc; 2007 Jul 04; 107(7):251-8. PubMed ID: 17682112
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A, Mauskop A, Diener HC, Schwalen S, Pfeil J.
    Headache; 2006 Jul 04; 46(7):1151-60. PubMed ID: 16866719
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
    Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, Ertas M, Lanteri-Minet M, Reuter U, Sánchez Del Río M, Schoenen J, Schwalen S, van Oene J, TOPMAT-MIG-303 Investigators Group.
    Lancet Neurol; 2007 Dec 04; 6(12):1054-62. PubMed ID: 17988947
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb 04; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 18. Topiramate in migraine prevention: a double-blind, placebo-controlled study.
    Storey JR, Calder CS, Hart DE, Potter DL.
    Headache; 2001 Feb 04; 41(10):968-75. PubMed ID: 11903524
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials.
    Adelman J, Freitag FG, Lainez M, Shi Y, Ascher S, Mao L, Greenberg S, Hulihan J.
    Pain Med; 2008 Mar 04; 9(2):175-85. PubMed ID: 18298700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.